TARAbenzinga

Protara Therapeutics Announces Conference Call And Webcast To Review Interim Data From Phase 2 ADVANCED-2 Trial Of TARA-002 In Patients with NMIBC On Monday, April 28, 2025

Summary

No summary available.

Original Article

Read the full article from the original source for complete details and context.

Read Full Article

Article published on April 23, 2025 by benzinga